SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-20-014917
Filing Date
2020-01-27
Accepted
2020-01-27 09:38:04
Documents
1
Effectiveness Date
2020-01-27

Document Format Files

Seq Description Document Type Size
1 15-12B d856735d1512b.htm 15-12B 9288
  Complete submission text file 0001193125-20-014917.txt   10312
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-37833 | Film No.: 20547334
SIC: 2836 Biological Products, (No Diagnostic Substances)